Abstract

INTRODUCTION

Sumac (Rhus coriaria L., Anacardiaceae) is traditionally used edible-plant in the Anatolia. Although, it has been preferred in alternative therapeutic approaches due to the presence of many bioactive phytochemicals, the literature survey demonstrated limited works have been undertaken for analyzing the anticancer and antiproliferative activities of the extracts.

METHODS

Therefore, the current research was aimed to evaluate totally anticancer potentials of extracts from R. coriaria L. fruits for contribution to medicinal and traditional uses of sumac. In this respect, anticancer and antiproliferative potentials, lysosomal and lactate dehydrogenase inhibitory effects were determined against A549, H1299 and H460 human lung cancer cell lines.

RESULTS

The results revealed almost all the extracts of sumac exhibited powerful anticancer and cytotoxic activities in a time and dose dependent manner. Among the extracts, aqueous and methanolic extracts were found to be highly cytotoxic with IC50 values in range of 5,08 – 6,49 µg/mL against all tested human lung cancer cells. It was observed that cell growth and cell viability in cancer cell lines were inhibited by the extracts. Additionally, increasing extracts exposure time and dose resulted in increasing the lysosomal functions and membrane permeability in the cell lines.

DISCUSSION AND CONCLUSION

Consequently, these findings suggest that sumac has potential uses in cancer therapy as an alternative herbal therapeutic agent as well as their uses as food and spice.